Bayer Schering Pharma Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 05 | Dec 04 | Dec 03 | |
|---|---|---|---|
| Revenue | 6,286.8 | 6,695.1 | 6,309.0 |
| Cost of Goods Sold | 1,487.6 | 1,645.5 | 1,718.0 |
| Gross Profit | 4,799.2 | 5,049.6 | 4,591.0 |
| Gross Profit Margin | 76.3% | 75.4% | 72.8% |
| SG&A Expense | 3,287.9 | 3,607.5 | 3,407.0 |
| Depreciation & Amortization | 412.2 | 416.1 | 393.0 |
| Operating Income | 1,099.1 | 1,026.0 | 791.0 |
| Operating Margin | 17.5% | 15.3% | 12.5% |
| Nonoperating Income | 13.0 | 1.4 | 171.6 |
| Nonoperating Expenses | -- | 54.6 | 13.6 |
| Income Before Taxes | 1,112.2 | 968.7 | 949.0 |
| Income Taxes | 409.8 | 326.1 | 329.0 |
| Net Income After Taxes | 702.4 | 642.6 | 620.0 |
| Continuing Operations | 696.4 | 642.6 | 616.0 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 696.4 | 642.6 | 616.0 |
| Total Net Income | 696.4 | 642.6 | 616.0 |
| Net Profit Margin | 11.1% | 9.6% | 9.8% |
| Diluted EPS from Total Net Income ($) | -- | -- | -- |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
